Showing results (11-20 of 33) with videos related to
Sort By:
Pageof 4
Pediatric Pulmonology|July 4, 2018
Tracheostomy in children: Epidemiology and clinical outcomesCatherine D Sanders, Jennifer S Guimbellot, Marianne S Muhlebach, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 12, 2025
Tobacco smoke exposure is associated with diminished longitudinal benefit of elexacaftor/tezacaftor/ivacaftor in cystic fibrosisWilliam T Harris, Elizabeth H Baker, Jennifer S Guimbellot, et al.Genes|June 4, 2020
Human Nasal Epithelial Organoids for Therapeutic Development in Cystic FibrosisZhongyu Liu, Justin D Anderson, Lily Deng, et al.BMC Medical Genomics|March 27, 2009
Correlation of microRNA levels during hypoxia with predicted target mRNAs through genome-wide microarray analysisJennifer S Guimbellot, Stephen W Erickson, Tapan Mehta, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 20, 2024
Association between biomarkers of tobacco smoke exposure and clinical efficacy of ivacaftor in the G551D observational trial (GOAL)Elizabeth Baker, William T Harris, Jennifer S Guimbellot, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 28, 2025
Pharmacokinetic assessment of elexacaftor/tezacaftor/ivacaftor and their metabolites in maternal blood, cord blood, the neonate, and breastmilk of a cystic fibrosis carrier mother/affected fetus dyadRachel G Sinkey, Bryan Garcia, Christopher Miles Fowler, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 21, 2023
Mobile health platform for self-management of pediatric cystic fibrosis: Impact on patient-centered care outcomesGabriela R Oates, Cathy Mims, Robin Geurs, et al.Pharmacotherapy|December 24, 2024
Pilot and feasibility study of dietary composition with elexacaftor-tezacaftor-ivacaftor concentrations in people with cystic fibrosisNatalie R Rose, Julianna Bailey, Justin D Anderson, et al.Pediatric Pulmonology|August 4, 2022
Plasma and cellular ivacaftor concentrations in patients with cystic fibrosisJennifer S Guimbellot, Kevin J Ryan, Justin D Anderson, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 12, 2020
Variable cellular ivacaftor concentrations in people with cystic fibrosis on modulator therapyJennifer S Guimbellot, Kevin J Ryan, Justin D Anderson, et al.Pageof 4